UnknownNot Applicable

Photodynamic Therapy in Treatment of Verrucae

Egypt80 participantsStarted 2020-01-01

Plain-language summary

To assess the efficacy (clinically and dermoscopically) and safety of photodynamic therapy using intralesional injection of 4% methylene blue solution as a photosensitizer with IPL versus IPL only in treatment of warts.

Who can participate

Age range16 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Age:Above 16 years old.
✓. Sex:Both males and female patients.
✓. Clinically and dermoscopically documented verruca.
✓. No verruca treatment in the last 2 weeks.

Exclusion criteria

✕. History of photosensitivity disorder.
✕. Pregnant and lactating females.
✕. Diseases with risk of koebnerization e.g. Psoriasis and Lichen planus.
✕. Anogenital warts.
✕. Warts on head and neck.

What they're measuring

disappearance of verruca

Timeframe: 10 weeks

Trial details

NCT IDNCT04620785

SponsorAlexandria University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-05-01

View on ClinicalTrials.gov More Verruca Vulgaris trials